Novozymes A/S (CPH:NSIS.B)
436.60
-14.00 (-3.11%)
Sep 4, 2026, 4:59 PM CET
Novozymes Market Cap
Novozymes has a market cap or net worth of 203.42 billion as of September 4, 2026. Its market cap has increased by 8.75% in one year.
Market Cap
203.42B
Enterprise Value
224.05B
Revenue
32.13B
Ranking
n/a
PE Ratio
43.14
Stock Price
436.60
ChartMarket Cap Chart
Since February 26, 2001, Novozymes's market cap has increased from 14.15B to 203.42B, an increase of 1,337.76%. That is a compound annual growth rate of 11.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 203.42B | 7.12% |
| Dec 30, 2025 | 189.89B | 0.24% |
| Dec 30, 2024 | 189.43B | 84.24% |
| Dec 29, 2023 | 102.82B | 5.66% |
| Dec 30, 2022 | 97.30B | -34.61% |
| Dec 30, 2021 | 148.80B | 51.92% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DSV A/S | 312.79B |
| Danske Bank | 300.35B |
| A.P. Møller - Mærsk | 299.05B |
| Vestas Wind Systems | 206.94B |
| Ørsted | 178.34B |
| Genmab | 129.85B |
| Carlsberg | 121.45B |
| Coloplast | 107.88B |